Preparing your results

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Requirement of ATM-dependent phosphorylation of brca1 in the DNA damage response to double-strand breaks.

Science (New York, N.Y.) | Nov 5, 1999

http://www.ncbi.nlm.nih.gov/pubmed/10550055

The Brca1 (breast cancer gene 1) tumor suppressor protein is phosphorylated in response to DNA damage. Results from this study indicate that the checkpoint protein kinase ATM (mutated in ataxia telangiectasia) was required for phosphorylation of Brca1 in response to ionizing radiation. ATM resides in a complex with Brca1 and phosphorylated Brca1 in vivo and in vitro in a region that contains clusters of serine-glutamine residues. Phosphorylation of this domain appears to be functionally important because a mutated Brca1 protein lacking two phosphorylation sites failed to rescue the radiation hypersensitivity of a Brca1-deficient cell line. Thus, phosphorylation of Brca1 by the checkpoint kinase ATM may be critical for proper responses to DNA double-strand breaks and may provide a molecular explanation for the role of ATM in breast cancer.

Pubmed ID: 10550055 RIS Download

Mesh terms: Amino Acid Sequence | Ataxia Telangiectasia | Ataxia Telangiectasia Mutated Proteins | BRCA1 Protein | Breast Neoplasms | Cell Cycle Proteins | Cell Line | DNA Damage | DNA Repair | DNA, Complementary | DNA-Binding Proteins | Female | Gamma Rays | Genes, BRCA1 | Genetic Predisposition to Disease | HeLa Cells | Heterozygote | Humans | Molecular Sequence Data | Mutation | Phosphorylation | Protein-Serine-Threonine Kinases | Recombinant Fusion Proteins | Tumor Suppressor Proteins

Research resources used in this publication

None found

Research tools detected in this publication

None found

Data used in this publication

None found

Associated grants

  • Agency: NIGMS NIH HHS, Id: GM44664

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.